Pay in 4 interest-free payments of $6.77 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
living with diabetes and over 100 million affected by obesity, the rising demand for these drugs has caused global shortages
The term GLP-1s refers to medications that mimic or activate the hormone glucagonlike peptide1
As demand grows, new research finds covering GLP-1 medications will drive up premiums for employer-provided coverage by as much as 14 percent , even when access is limited to patients with the highest need
Understanding these mechanisms helps clinicians provide appropriate counselling and implement preventative strategies
Insulin binding to brain capillaries is reduced in genetically obese, hyperinsulinemic zucker rats
An effective oral GLP-1 could challenge the current injectable market leaders and avoid supply chain issues
US$ 20.55
US$ 23.25
US$ 24.08
US$ 24.04
